Table 4.
Lung function assessment values (mean ±[s.d.], n = 22) in two experimental conditions; Pseudoephedrine (PSE) and placebo(PLA), *indicates significant difference in the prepost change between treatments, P < 0.05.
| Variable | Pre | Post | P value | Difference Pre-Post |
|---|---|---|---|---|
| Lung function (l) | ||||
| FEV1 (PSE) | ||||
| FEV1 (PLA) | 5.21 [0.7] | 5.36 [0.6] | 0.15 [0.7] | |
| 5.19 [0.6] | 5.17 [0.6] | −0.02 [0.6] | ||
| 95% CI for difference | 0.02* | 0.12, 0.40 | ||
| pre-post between conditions | (r = 0.30) | |||
| FVC (PSE) | 6.46 [0.5] | 6.58 [0.6] | 0.12 [0.6] | |
| FVC (PLA) | 6.51 [0.5] | 6.47 [0.6] | −0.04 [0.6] | |
| 95% CI for difference | 0.01* | 0.12, 0.36 | ||
| pre-post between conditions | (r = 0.39) | |||
| FER1 (%) (PSE) | 79.59 [8.1] | 80.61 [7.7] | 0.95 [7.9] | |
| FER1 (%) (PLA) | 78.90 [7.2] | 79.26 [7.2] | 0.36 [7.2] | |
| 95% CI for difference | 0.45 | −0.90, 2.23 | ||
| pre-post between conditions | (r = 0.20) | |||